Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes Mellitus

NCT02958956 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02958956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02958956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes Mellitus
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
January 1, 1997
Completion date
May 29, 2015
Enrollment
236,507 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, cancer